Results 241 to 250 of about 254,354 (315)

Venetoclax plus azacitidine in higher-risk myelodysplastic syndromes: a treatment-purpose framework for interpreting response depth. [PDF]

Front Med (Lausanne)
Zou X, Bu J, Chu A, Shi L, Zhang Z, Zheng Q, Luo M.   +6 more
europepmc   +1 more source

Treatment Tolerability in Older Adults With Advanced Cancer Receiving Geriatric Assessment-Guided Versus Oncologist-Guided Primary Treatment Modification: Secondary Analysis of the GAP70+ Trial. [PDF]

JCO Oncol Pract
Mohamed MR, Rich DQ, Lund JL, Seplaki CL, Flannery M, Alieldin R, Chen Y, Ramsdale E, Wells M, Magnuson A, Loh KP, Dunne R, Janelsins M, Mohile S.   +13 more
europepmc   +1 more source

Novel intravenous human IVIG in patients with secondary immunodeficiency: Interim analysis of a multicenter, prospective, non-interventional study. [PDF]

Int J Clin Pharmacol Ther
Bauhofer A, Aigner S, Borte S.
europepmc   +1 more source

Vornorexant versus lemborexant for insomnia disorder: a systematic review and network meta-analysis. [PDF]

Int J Neuropsychopharmacol
Kishi T, Sakuma K, Kitajima T, Iwata N.
europepmc   +1 more source

Oral Retinol, Alone or Combined with Medical Photoprotection, in Patients with Actinic Keratosis: A Randomized, Open-Label, Prospective, Multicentric Study. [PDF]

Dermatol Ther (Heidelb)
Ardigò M, Burlando M, Campione E, Nazzaro G, Foggi G, Colombo F, Alfano S, Milani M, Marzano AV.   +8 more
europepmc   +1 more source

Structure-Function Relationships in Polysaccharide-Iron Complexes: Molecular Characterization, Acid-Stress Release Stability, and Gastrointestinal Tolerability. [PDF]

Pharmaceutics
Qi X, Zhu H, Yan X, Kang X, Xiao D, Sha X.   +5 more
europepmc   +1 more source